Focus A-Eye LLC, a specialized medical education and innovation forum dedicated to advancing the application of artificial intelligence (AI) in ophthalmology, will launch the inaugural Focus A-Eye Summit on Saturday, May 2, 2026 in Denver, Colorado.
Experts convened by the National Institutes of Health (NIH) have identified five elements of a brain-based condition that has emerged as a leading cause of vision impairment starting in childhood in the United States and other industrialized nations. Known as cerebral (or cortical) visual impairment (CVI), some estimates suggest that at least 3% of primary school children exhibit CVI-related visual problems, which vary, but may include difficulty visually searching for an object or person or understanding a scene involving complex motion. Their report, based on evidence and expert opinion, was published today in Ophthalmology.
Recent strides toward understanding dry eye are leading to better and longer-lasting therapies for the millions of people in the U.S. who are affected by the condition.
Current therapies for dry eye provide symptomatic relief: steroids control inflammation, antibiotics counter infection, and artificial tears replenish moisture. But such approaches give only short-term relief for some people and require frequent reapplication. They also fail to address the underlying causes of dry eye. (more…)